Denmark Sweden Norway Finland
Human Glucosylceramidase Protein, His Tag
ACROBiosystems

Human Glucosylceramidase Protein, His Tag

Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose. Thereby, it plays a central role in the degradation of complex lipids and the turnover of cellular membranes. Through the production of ceramides,it participates in the PKC-activated salvage pathway of ceramide formation and plays a role in cholesterol metabolism. It may either catalyze the glucosylation of cholesterol, through a transglucosylation reaction that transfers glucose from glucosylceramide to cholesterol. Defects in Glucosylceramidase are the cause of Gaucher disease, also known as glucocerebrosidase deficiency. Gaucher disease is the most prevalent lysosomal storage disease, characterized by accumulation of glucosylceramide in the reticulo-endothelial system. Currently, enzyme replacement therapy is used to treat patients with the disease.

GLE-H52H3-202 1mg*1

Sign in to see prices and add items to your cart

Availability

Available in the following countries:

Denmark Denmark
Norway Norway
Sweden Sweden
Finland Finland
Got any questions?

Get in touch with one of our specialists

Henrik Tind Nielsen

Henrik Tind Nielsen

CCO & Product Specialist Automation

Cristina Battagli

Cristina Battagli

Product Specialist: Diagnostics, Metabolomics, Imaging & Cell Biology

News and Promotions
Kem-En-Tec Nordic A/S Logo
Kem-En-tec Nordic A/S
 Kuldyssen 10, 2630 Taastrup
 +45 3927 1777
 Parkvägen 12, 448 34 Floda
 +46 18 149000
 info@kem-en-tec-nordic.com
Follow Us
Sign up for our newsletter
Yes, I give permission to store my data